RNA Isolation and Enrichment Reagent Market Key Players, SWOT Analysis, Key Indicators and Forecast to 2030

RNA isolation and enrichment is part of the next-generation sequencing technique or studying viral genome variability. RNA isolation is the process of purifying RNA from biological samples to prevent RNA from degrading. RNA enrichment helps to sequence-specific RNA instead of the entire genome to obtain more accurate results in next-generation sequencing.

The RNA isolation and enrichment reagent are used to isolate RNA from human, animal, plant, yeast, bacteria or virus and can perform well in large tissue by simultaneous extraction. RNA extracted with the help of RNA isolation and enrichment reagent can be used for RT-PCR, RNase protection assay, molecular cloning, northern blot analysis and others.

Reduced and delayed research and development activity rate across biopharmaceutical and biotech industry is expected to reduce the demand for RNA isolation and enrichment reagent for short-term. However, this is projected to remain positive in long term scenario and growth trends will remain positive for the next decade.

Manufacturing and supply chain activities of RNA isolation and enrichment reagent market are expected to hamper due to lockdown situation across the dominant regions of the world amid Covid-19 pandemic.

The rise in the prevalence of viral infections is expected to drive RNA isolation and enrichment reagent market growth. With developments in next-generation sequencing activities, the leading industry players are investing in the RNA isolation and enrichment reagent market.

Increasing technological advancements in genetic engineering are expected to boost RNA isolation and enrichment reagent market growth. Increasing awareness and diagnosis rate is expected to propel RNA isolation and enrichment reagent market growth. The requirement of highly skilled labour and time-intensive sample preparation method can hinder RNA isolation and enrichment reagent market growth.

TRIzol reagent is expected to hold the majority revenue share in the RNA isolation and enrichment reagent market during the forecast period. Based on application, diagnostics hold the major share of the RNA isolation and enrichment reagent market with increasing cancer and infectious disease cases.

Get Sample of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12746

Whereas, drug discovery will observe a significant rise in demand for the RNA isolation and enrichment reagent market due to increasing investment for research and development activities. Biopharmaceutical companies and clinical laboratories are the largest end-user in the RNA isolation and enrichment reagent market with increasing diagnosis rate.

North America will continue to dominate the RNA isolation and enrichment reagent market in the coming decade with a high rate of prevalence of influenza infections. Europe is the second leading region in RNA isolation and enrichment reagent market with increased investments towards research and development activities.

Asia-pacific is lucrative with a higher growth rate in the RNA isolation and enrichment reagent market during the forecast period with a large patient population and diagnosis rate in the region. The Middle East and Africa are expected to observe the least growth in RNA isolation and enrichment reagent market due to less healthcare expenditure in the region.

Poor economic conditions in the Middle East and Africa make these market untapped regions with fewer growth opportunities in RNA isolation and enrichment reagent market.

Some key players contributing in RNA isolation and enrichment reagent market are

• Thermo Fisher ScientificInc.
• IlluminaInc.
• Agilent Technologies Inc.
• F. Hoffmann-La Roche AG
• Pacific Biosciences of CaliforniaInc.
• Oxford Nanopore Technologies
• QIAGEN
• Fluidign Corporation
• Bioline
• Takara Bio Inc.
• ArcherDXInc.

Request for TOC @ https://www.futuremarketinsights.com/toc/rep-gb-12746